[Clinical course of cytomegalovirus retinitis with the different antiretroviral therapies in our hospital].
A study of protease inhibitors on CMV retinitis in HIV infected hospital patients. A retrospective study was performed in 485 diagnosed of AIDS, between January, 1990 and December 1998. Among those, 81 patients who were diagnosed of CMV retinitis, the following was studied: anti-retroviral treatment, anti CMV treatment, survival time and CD4 lymphocyte count. Treatment with protease inhibitors in HIV patients showed an increase in life expectancy, reduced the incidence of CMV retinitis and a reduction in CMV retinitis prevention treatment was observed. Treatment with protease inhibitors has reduced the rate of CMV retinitis in HIV patients.